InsiderTrades

Form 4 for EW Edwards Lifesciences

Accepted 2024-01-05 00:00:00 ET · period of report 2024-01-05 · accession 0001225208-24-000480 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-01-05 2024-01-05 EW MUSSALLEM MICHAEL A Dir S - Sale+OE $72.98 -29.4K 4,486 -87% -$2.14M
D 2024-01-05 2024-01-05 EW MUSSALLEM MICHAEL A Dir M - OptEx $36.75 +29.4K 33.8K +654% +$1.08M
D 2024-01-05 2024-01-05 EW MUSSALLEM MICHAEL A Dir M - OptEx $0.00 -29.4K 117.4K -20% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-05 S D 2,500 $73.46 31,335.82 D — — (F2) This transaction was executed in multiple trades at prices ranging from $73.42 to $73.59. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
2 Common Common Stock 2024-01-05 M A 29,350 $36.75 33,835.82 D — —
3 Common Common Stock 2024-01-05 S D 26,850 $72.94 4,485.82 D — — (F3) This transaction was executed in multiple trades at prices ranging from $72.41 to $73.41. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
4 Derivative Employee Stock Option (Right to Acquire) 2024-01-05 M D 29,350 $0.00 117,400 D $36.75 · 2017-06-11 to 2024-05-10 29,350 Common Stock